FHTX Foghorn Therapeutics Inc.
Nasdaq · SEC CIK 1822462 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 108 since 2021-07-14, latest 2026-06-25 16:06
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| GOTTSCHALK ADRIAN | CEO, Dir | — | — |
Transactions 29
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2026-04-13 16:01 | 2026-04-09+ | FHTX | GOTTSCHALK ADRIAN | CEO, Dir | G - Gift | $0.00 | 0 | 270.9K | New | $0 |
| MI | 2025-04-28 | 2025-04-25 | FHTX | GOTTSCHALK ADRIAN | CEO, Dir | G - Gift | $0.00 | 0 | 511.7K | New | $0 |
| MI | 2025-04-10 | 2025-04-09 | FHTX | GOTTSCHALK ADRIAN | CEO, Dir | G - Gift | $0.00 | 0 | 511.7K | New | $0 |
| DMT | 2024-09-24 | 2024-09-20+ | FHTX | Costa Carlos | CHRO | M - OptEx | $3.72 | +36.6K | 35.8K | New | +$136.2K |
| DMT | 2024-09-24 | 2024-09-20+ | FHTX | Costa Carlos | CHRO | S - Sale+OE | $10.04 | -36.6K | 0 | -100% | -$367.7K |
| DT | 2024-09-20 | 2024-09-18 | FHTX | Costa Carlos | CHRO | M - OptEx | $3.72 | +11.6K | 11.6K | New | +$43.1K |
| DT | 2024-09-20 | 2024-09-18 | FHTX | Costa Carlos | CHRO | S - Sale+OE | $10.05 | -11.6K | 0 | -100% | -$116.3K |
| DMT | 2024-09-18 | 2024-09-16+ | FHTX | Costa Carlos | CHRO | M - OptEx | $3.72 | +10.7K | 10.3K | New | +$39.7K |
| DMT | 2024-09-18 | 2024-09-16+ | FHTX | Costa Carlos | CHRO | S - Sale+OE | $10.04 | -10.7K | 0 | -100% | -$107.1K |
| T | 2024-09-11 | 2024-09-09 | FHTX | Bellon Steven F. | CSO | S - Sale | $9.50 | -20.0K | 102.0K | -16% | -$190.0K |
| 2024-03-12 | 2024-03-11 | FHTX | Cavalie Fanny | Chief Strategy, Bus Ops Off | S - Sale | $6.56 | -11.0K | 76.0K | -13% | -$72.2K | |
| D | 2023-08-18 | 2023-08-16 | FHTX | Agresta Samuel | Chief Medical Off | M - OptEx | $3.72 | +311.3K | 311.3K | New | +$1.16M |
| D | 2023-08-18 | 2023-08-16 | FHTX | Agresta Samuel | Chief Medical Off | S - Sale+OE | $8.25 | -311.3K | 0 | -100% | -$2.57M |
| I | 2023-08-18 | 2023-08-17 | FHTX | GOTTSCHALK ADRIAN | CEO, Dir | G - Gift | $0.00 | +63.0K | 511.7K | +14% | $0 |
| 2023-08-18 | 2023-08-17 | FHTX | GOTTSCHALK ADRIAN | CEO, Dir | G - Gift | $0.00 | -63.0K | 0 | -100% | $0 | |
| MI | 2023-05-31 | 2023-05-26 | FHTX | GOTTSCHALK ADRIAN | CEO, Dir | G - Gift | $0.00 | 0 | 448.7K | New | $0 |
| M | 2023-02-22 | 2022-02-10+ | FHTX | GOTTSCHALK ADRIAN | CEO, Dir | G - Gift | $0.00 | -127.8K | 63.0K | -67% | $0 |
| MI | 2023-02-22 | 2022-10-25+ | FHTX | GOTTSCHALK ADRIAN | CEO, Dir | J - Other | $0.00 | -4,371 | 444.3K | -1.0% | $0 |
| MI | 2023-02-22 | 2022-02-10+ | FHTX | GOTTSCHALK ADRIAN | CEO, Dir | G - Gift | $0.00 | +127.8K | 448.7K | +40% | $0 |
| 2023-02-22 | 2022-10-25 | FHTX | GOTTSCHALK ADRIAN | CEO, Dir | J - Other | $0.00 | +4,371 | 67.4K | +7% | $0 | |
| D | 2022-09-19 | 2022-09-16 | FHTX | GOTTSCHALK ADRIAN | CEO, Dir | M - OptEx | $0.54 | +40.0K | 186.5K | +27% | +$21.6K |
| D | 2022-09-14 | 2022-09-13 | FHTX | GILL SIMBA | Dir | G - Gift | $0.00 | -47.9K | 34.1K | -58% | $0 |
| D | 2022-09-14 | 2022-09-12 | FHTX | GILL SIMBA | Dir | M - OptEx | $0.73 | +82.0K | 82.0K | New | +$59.9K |
| D | 2022-08-15 | 2022-08-11 | FHTX | Bellon Steven F. | CSO | M - OptEx | $3.72 | +1,858 | 122.0K | +2% | +$6,912 |
| DM | 2022-05-27 | 2022-05-25 | FHTX | Bellon Steven F. | CSO | M - OptEx | $3.26 | +4,392 | 120.1K | +4% | +$14.3K |
| 2021-12-16 | 2021-12-14 | FHTX | KADOCH CIGALL | Dir, 10% | G - Gift | $0.00 | -333.3K | 295.0K | -53% | $0 | |
| D | 2021-12-13 | 2021-12-09 | FHTX | DECICCO CARL | CSO | M - OptEx | $3.72 | +104.3K | 362.7K | +40% | +$388.0K |
| D | 2021-08-23 | 2021-08-20 | FHTX | GOTTSCHALK ADRIAN | CEO, Dir | M - OptEx | $0.54 | +23.0K | 446.5K | +5% | +$12.4K |
| D | 2021-08-11 | 2021-08-09 | FHTX | Reine Allan | CFO | M - OptEx | $3.72 | +26.9K | 53.8K | +100% | +$100.0K |
Purchase Sale Sale after option exercise All abbreviations